BusinessUpdated 1 hr ago
Lab Rats series: A Bengaluru startup’s bid to drug the undruggable

Backed by an ₹86 crore government grant and ₹70 crore Series A funding, Peptris Technologies is leveraging generative AI to build a preclinical pipeline targeting rare diseases and previously undruggable proteins.
Continue reading on Mint
Read full story Hello Headlines links you to the original publisher for the full story.

